137 related articles for article (PubMed ID: 31028739)
1. Schizandrin A enhances the efficacy of gefitinib by suppressing IKKβ/NF-κB signaling in non-small cell lung cancer.
Xian H; Feng W; Zhang J
Eur J Pharmacol; 2019 Jul; 855():10-19. PubMed ID: 31028739
[TBL] [Abstract][Full Text] [Related]
2. Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.
Hu Y; Zang J; Cao H; Wu Y; Yan D; Qin X; Zhou L; Fan F; Ni J; Xu X; Sha H; Liu S; Yu S; Wang Z; Ma R; Wu J; Feng J
Oncotarget; 2017 Feb; 8(9):15802-15814. PubMed ID: 28178657
[TBL] [Abstract][Full Text] [Related]
3. Schizandrin A Inhibits Microglia-Mediated Neuroninflammation through Inhibiting TRAF6-NF-κB and Jak2-Stat3 Signaling Pathways.
Song F; Zeng K; Liao L; Yu Q; Tu P; Wang X
PLoS One; 2016; 11(2):e0149991. PubMed ID: 26919063
[TBL] [Abstract][Full Text] [Related]
4. Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the Toll-like receptor 4-dependent MyD88/IKK/NF-κB signaling pathway in lipopolysaccharide-induced microglia.
Zeng KW; Zhang T; Fu H; Liu GX; Wang XM
Eur J Pharmacol; 2012 Oct; 692(1-3):29-37. PubMed ID: 22698579
[TBL] [Abstract][Full Text] [Related]
5. Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer.
Li Z; Liao J; Yang Z; Choi EY; Lapidus RG; Liu X; Cullen KJ; Dan H
Br J Cancer; 2019 Feb; 120(3):306-316. PubMed ID: 30585254
[TBL] [Abstract][Full Text] [Related]
6. Schizandrin A can inhibit non‑small cell lung cancer cell proliferation by inducing cell cycle arrest, apoptosis and autophagy.
Zhu L; Wang Y; Lv W; Wu X; Sheng H; He C; Hu J
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34643254
[TBL] [Abstract][Full Text] [Related]
7. Gomisin N enhances TNF-α-induced apoptosis via inhibition of the NF-κB and EGFR survival pathways.
Waiwut P; Shin MS; Inujima A; Zhou Y; Koizumi K; Saiki I; Sakurai H
Mol Cell Biochem; 2011 Apr; 350(1-2):169-75. PubMed ID: 21188622
[TBL] [Abstract][Full Text] [Related]
8. Schizandrin A exhibits potent anticancer activity in colorectal cancer cells by inhibiting heat shock factor 1.
Chen BC; Tu SL; Zheng BA; Dong QJ; Wan ZA; Dai QQ
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32110802
[TBL] [Abstract][Full Text] [Related]
9. RNF25 promotes gefitinib resistance in EGFR-mutant NSCLC cells by inducing NF-κB-mediated ERK reactivation.
Cho JH; You YM; Yeom YI; Lee DC; Kim BK; Won M; Cho BC; Kang M; Park S; Yang SJ; Kim JS; Kim JA; Park KC
Cell Death Dis; 2018 May; 9(6):587. PubMed ID: 29789542
[TBL] [Abstract][Full Text] [Related]
10. TPCA-1 is a direct dual inhibitor of STAT3 and NF-κB and regresses mutant EGFR-associated human non-small cell lung cancers.
Nan J; Du Y; Chen X; Bai Q; Wang Y; Zhang X; Zhu N; Zhang J; Hou J; Wang Q; Yang J
Mol Cancer Ther; 2014 Mar; 13(3):617-29. PubMed ID: 24401319
[TBL] [Abstract][Full Text] [Related]
11. LATS2 inhibits the activity of NF-κ B signaling by disrupting the interaction between TAK1 and IKKβ.
Yao F; Zhou W; Zhong C; Fang W
Tumour Biol; 2015 Sep; 36(10):7873-9. PubMed ID: 25946971
[TBL] [Abstract][Full Text] [Related]
12. Cucurbitacin B Induces the Lysosomal Degradation of EGFR and Suppresses the CIP2A/PP2A/Akt Signaling Axis in Gefitinib-Resistant Non-Small Cell Lung Cancer.
Liu P; Xiang Y; Liu X; Zhang T; Yang R; Chen S; Xu L; Yu Q; Zhao H; Zhang L; Liu Y; Si Y
Molecules; 2019 Feb; 24(3):. PubMed ID: 30759826
[TBL] [Abstract][Full Text] [Related]
13. Schizandrin protects H9c2 cells against lipopolysaccharide-induced injury by downregulating Smad3.
Zhang X; Zhao Y; Bai D; Yuan X; Cong S
J Biochem Mol Toxicol; 2019 May; 33(5):e22301. PubMed ID: 30801894
[TBL] [Abstract][Full Text] [Related]
14. Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades.
Wang X; Yu Z; Wang C; Cheng W; Tian X; Huo X; Wang Y; Sun C; Feng L; Xing J; Lan Y; Sun D; Hou Q; Zhang B; Ma X; Zhang B
J Exp Clin Cancer Res; 2017 Jul; 36(1):93. PubMed ID: 28701209
[TBL] [Abstract][Full Text] [Related]
15. Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
Wu M; Yuan Y; Pan YY; Zhang Y
Mol Med Rep; 2014 Aug; 10(2):931-8. PubMed ID: 24840891
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor (EGF) activates nuclear factor-kappaB through IkappaBalpha kinase-independent but EGF receptor-kinase dependent tyrosine 42 phosphorylation of IkappaBalpha.
Sethi G; Ahn KS; Chaturvedi MM; Aggarwal BB
Oncogene; 2007 Nov; 26(52):7324-32. PubMed ID: 17533369
[TBL] [Abstract][Full Text] [Related]
17. Schizandrin B attenuates angiotensin II induced endothelial to mesenchymal transition in vascular endothelium by suppressing NF-κB activation.
You S; Qian J; Wu G; Qian Y; Wang Z; Chen T; Wang J; Huang W; Liang G
Phytomedicine; 2019 Sep; 62():152955. PubMed ID: 31146168
[TBL] [Abstract][Full Text] [Related]
18. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
[TBL] [Abstract][Full Text] [Related]
19. Pentacyclic Triterpenoids Inhibit IKKβ Mediated Activation of NF-κB Pathway: In Silico and In Vitro Evidences.
Patil KR; Mohapatra P; Patel HM; Goyal SN; Ojha S; Kundu CN; Patil CR
PLoS One; 2015; 10(5):e0125709. PubMed ID: 25938234
[TBL] [Abstract][Full Text] [Related]
20. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
Zhang ZL; Jiang QC; Wang SR
Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]